SciELO - Scientific Electronic Library Online

vol.102 issue1Varicela en el niño inmunocomprometido en la era del aciclovirEvolución de la infección por virus varicela zósteren niños infectados perinatalmente conel virus de la inmunodeficiencia humana author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Archivos argentinos de pediatría

Print version ISSN 0325-0075On-line version ISSN 1668-3501


GOLDSTEIN, Gustavo et al. Aciclovir oral para profilaxis posexposición familiar a varicela. Arch. argent. pediatr. [online]. 2004, vol.102, n.1, pp.13-17. ISSN 0325-0075.

Objective. To determine whether administration of acyclovir during the incubation period of varicellacan prevent the development of disease. Population, material & methods. Oral acyclovir (20-40mg/kg/d) was administered during five days to 26 children, nine days after the initial exposure to a household contact with varicella. Development of clinical disease and seroconversion in this group of children were compared to a control group of 12 children exposed to varicella zoster virus who did not receive prophylactic acyclovir. The percentage of patients who presented seroconversion after receiving acyclovir was evaluated by immunofluorescence. Results. None of the children receiving prophylaxisdeveloped varicella (0/26) while all the children not receiving prophylaxis developed the disease (12/12). Taking into account all the patients (26) that received acyclovir, independently of the administered dose, 7 were lost (26.9%). Of the remaining 19, 17 presented seroconversion (89.5%, 95% confidence interval 66.9-98.7%) and 2 did not (10.5%). Conclusion. Prophylactic administration of oral acyclovir prevented development of varicella but did not alter seroconversion rates in susceptible children exposed to household contacts. None of the patients that received prophylactic treatment with acyclovir (independently of the administereddose) developed clinical varicella, while 89.5% ofthem (excluding lost cases) had serological evidence of varicella-zoster infection.

Keywords : Acyclovir; Prophylaxis; Varicella.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License